Maxim Group Starts Ritter Pharmaceuticals (RTTR) at Buy, $7 PT
Tweet Send to a Friend
Maxim Group initiates coverage on Ritter Pharmaceuticals (NASDAQ: RTTR) with a Buy rating and a price target of $7.00.Analyst Jason ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE